Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series C | Alive

About Unidiag

Unidiag is a medical device and reagent manufacturer that specializes in the field of chemiluminescence immunoassay analyzer (CLIA) and reagent.

Unidiag Headquarters Location

Tower 10-208 No.09 Tianfu Avenue China Bio-medicine Industry Park

Beijing, Beijing,


+86 01064897870

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Unidiag

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Unidiag is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,485 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

  • When was Unidiag founded?

    Unidiag was founded in 2010.

  • Where is Unidiag's headquarters?

    Unidiag's headquarters is located at Tower 10-208 No.09, Beijing.

  • What is Unidiag's latest funding round?

    Unidiag's latest funding round is Series C.

  • Who are the investors of Unidiag?

    Investors of Unidiag include Huagai Capital, Tehua Investment, ChinaEquity Group, PUSU Capital, Guozhong Venture Capital Management and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.